<--- Back to Details
First PageDocument Content
Science / Medical ethics / Pharmaceutical industry / Design of experiments / Pharmacology / Clinical trial / Health Insurance Portability and Accountability Act / Informed consent / United States Department of Health and Human Services / Clinical research / Health / Research
Date: 2012-12-19 19:26:13
Science
Medical ethics
Pharmaceutical industry
Design of experiments
Pharmacology
Clinical trial
Health Insurance Portability and Accountability Act
Informed consent
United States Department of Health and Human Services
Clinical research
Health
Research

Add to Reading List

Source URL: www.research.ucsf.edu

Download Document from Source Website

File Size: 219,02 KB

Share Document on Facebook

Similar Documents

PROUD PROUD Participant Involvement meeting: Trial Design Date: Tuesday 9th September – 20.00 Venue: MRC Clinical Trials Unit at UCL, Aviation House, 125 Kingsway, Holborn, WC2B 6NH Contact person: Mitzy Gaf

DocID: 1vq4y - View Document

Clinical Review & Education JAMA | Special Communication Guidelines for Inclusion of Patient-Reported Outcomes in Clinical Trial Protocols

DocID: 1vmrb - View Document

For immediate release March 21, 2017 Infectex Announces Positive Phase 2b-3 Clinical Trial Results of SQ109 for the Treatment of Multidrug-Resistant Pulmonary Tuberculosis Moscow, Russia and Rockville, MD, USA -- Infecte

DocID: 1vkmw - View Document

DEPARTMENT OF HEALTH DRUG OFFICE DRUG REGISTRATION AND IMPORT/EXPORT CONTROL DIVISION Guidance Notes on the Application for Certificate for Clinical Trial/Medicinal Test Background

DocID: 1vkj3 - View Document

CLINICAL TRIAL OUTCOME DATABASE (CTOD) Novartis RA: Longitudinal Model-Based Meta-Analysis in Rheumatoid Arthritis: An Application Toward Model-Based Drug Development Authors I Demin, B Hamren, O Luttringer, G Pillai and

DocID: 1vbDv - View Document